Patient Perspectives on Phase 0 Clinical Trials
- 15 June 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (12) , 3689-3691
- https://doi.org/10.1158/1078-0432.ccr-07-4561
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The Ethics of Phase 0 Oncology TrialsClinical Cancer Research, 2008
- Oncologic Phase 0 Trials Incorporating Clinical Pharmacodynamics: from Concept to PatientClinical Cancer Research, 2008
- Designing Phase 0 Cancer Clinical TrialsClinical Cancer Research, 2008
- Phase 0 Trials: An Industry PerspectiveClinical Cancer Research, 2008
- Inhibition of poly (ADP-ribose) polymerase (PARP) by ABT-888 in patients with advanced malignancies: Results of a phase 0 trialJournal of Clinical Oncology, 2007
- Recruitment experience in a phase 0 trial of ABT-888, an inhibitor of poly (ADP-ribose) polymerase (PARP), in patients (pts) with advanced malignanciesJournal of Clinical Oncology, 2007